• English
  • Korean
  • Chinese
表紙
市場調査レポート - 239720

体外診断(IVD)市場とアプリケーション

In Vitro Diagnostic (IVD) Market & Applications - Forecast To 2017

発行 Markets and Markets
出版日 ページ情報 英文 418 Pages
価格
体外診断(IVD)市場とアプリケーション In Vitro Diagnostic (IVD) Market & Applications - Forecast To 2017
出版日: 2013年08月02日 ページ情報: 英文 418 Pages
概要

世界の体外診断(IVD)市場は2012年で492億米ドルの規模と評価されております。

当レポートでは、体外診断(IVD)市場とアプリケーションについて、技術、製品の種類、アプリケーションおよびエンドユーザーごとに分類して分析しております。さらに市場をセグメント、サブセグメントに分割し、網羅的分析と将来の予測を提供しております。また各デバイス市場の世界的シナリオに関する詳細な情報を提供するために、北米、欧州、BRICs諸国、日本およびその他の地域の各地域別に、細かいレベルで総合的に分析しつつ、概略下記内容でお届け致します。

第1章 はじめに

  • 要点
  • レポートの概要
  • カバーする市場
  • ステークホルダー
  • 調査方法

第2章 エグゼクティブサマリー

第3章 市場概要

  • はじめに
  • 市場セグメンテーション
  • 市場のダイナミクス
  • 成功の規範
  • 成功の規範
  • 市場シェア分析
  • サプライチェーンの分析
  • ペステル分析

第4章 世界の体外診断市場,技術別

  • はじめに
    • 臨床化学
    • 免疫化学/免疫
    • 血液学
    • 凝固
    • 微生物学
    • 分子診断学
    • 他の臨床機器

第5章 世界の体外診断市場,商品種類別

  • はじめに
  • 機器
  • 試薬
  • データ管理システムのソフトウェア/ハードウェア
  • サービス

第6章 世界の体外診断市場,アプリケーション別

  • はじめに
  • 糖尿病
  • 感染症
  • 腫瘍学/癌
  • 心臓病学
  • 腎臓学
  • 自己免疫疾患
  • 薬物検査
  • HIV /エイズ
  • その他

第7章 世界の体外診断市場,最終ユーザ別

  • はじめに
  • 実験室
  • 病院
  • 学業
  • ポイントオブケア検査
  • 患者の自己テスト
  • その他

第8章 地域分析

  • はじめに
  • 南北アメリカ
    • 米国
    • カナダ
    • メキシコ
    • ペルー
    • その他の南北アメリカ諸国
  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • その他の欧州諸国
  • 日本
  • BRICs諸国
    • ブラジル
    • ロシア
    • インド
    • 中国
  • その他の地域

第9章 競合環境

はじめに 新製品の発売 契約、提携、協業および合弁 合併と買収 その他の展開

第10章 企業プロフィール(概要、財務、製品・サービス、戦略および展開)*

  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • アークレイ株式会社
  • Bayer AG
  • Becton, Dickinson And Company
  • Biomerieux
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Diagnostica Stago Sas
  • Diasorin S.P.A.
  • Hologic, Inc.
  • 株式会社 堀場製作所
  • Johnson & Johnson
  • Novartis International Ag
  • Qiagen N.V.
  • Roche Diagnostics Limited
  • Siemens Healthcare
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

*概要、財務、製品・サービス、戦略および展開の詳細については非上場企業の場合はカバーできていない場合があります。

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Title: In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] - Forecast To 2017.

The global in vitro diagnostics market was valued at $49.2 billion in 2012. The factors likely to fuel the growth of the market include ongoing developments in analytical laboratory automation, swift progress in various fields of diagnosis such as point-of-care testing, molecular diagnosis, immunoassays, hematology, flow cytometry, and microbiology; and finally, the geographical market expansion within emerging countries.

The most important trend witnessed recently in the in vitro diagnostic industry is the trend of self-testing as opposed to patients visiting hospitals. This is one of the biggest factors responsible for the growth of point-of-care testing, as patients prefer self-testing so as to avoid unnecessary visits to the hospital. However, factors such as stringent regulatory frameworks and a shortage of budget are restraining the growth of this market. The global in vitro disgnostics market is expected to reach $69.1 billion by 2017, at a CAGR of 7% from 2012 to 2017.

In 2012, the Americas had accounted for the largest share of the global in vitro diagnostic market, followed by Europe. However, the BRIC countries represent the fastest-growing markets due to the economic growth, the rising number of chronic diseases, and an increasing awareness about the use of IVD tests to control the spread of diseases. Moreover, the economic slowdown, pricing pressures, and high competition in mature countries will compel companies to focus on emerging markets.

Scope of the Report

This research report categorizes the global IVD (In vitro diagnostic) market on the basis of technique, product type, application, and end-users. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to 2017. Each of the devices market is comprehensively analyzed at a granular level by geography (North America, Europe, BRIC, Japan and Rest of the World) to provide in-depth information on the global scenario. These regions are further analyzed at major country levels.

Global IVD Market, by Technique:

  • Immunochemistry
  • Clinical Chemistry
  • Molecular Diagnostics
  • Hematology
  • Microbiology
  • Coagulation
  • Other Clinical Instruments (clinical centrifuges, sample processers, washers, histology, cytology, and flow cytometry)

Global IVD Market, by Product Type:

  • Reagents
  • Instruments
  • Services
  • Data Management System Software/Hardware

Global IVD Market, by Application:

  • Diabetes
  • Infectious Diseases
  • Oncology
  • Cardiology
  • HIV/AIDS
  • Autoimmune Diseases
  • Drug Testing
  • Nephrology
  • Others (endocrine tests, blood analysis tests, pregnancy tests, and general clinical applications)

Global IVD Market, by End-Users:

  • Hospitals
  • Laboratories
  • Patient Self-testing
  • POCT (Point-of-Care Testing)
  • Academics (academic medical centers/research laboratories, university laboratories, etc.)
  • Others (blood banks, local public health laboratories, community clinics, home health agencies, nursing homes, and ambulatory surgical centers)

In Vitro Diagnostic Market, by Geography:

  • The Americas
    • U.S.
    • Canada
    • Mexico
    • Chile
    • Rest of America
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • U.K.
    • Rest of Europe
  • Japan
  • BRIC
    • Brazil
    • Russia
    • India
    • China
  • Rest of the World

Table of Contents

1. Introduction

  • 1.1. Key Take-Aways
  • 1.2. Report Description
  • 1.3. Markets Covered
  • 1.4. Stakeholders
  • 1.5. Research Methodology
    • 1.5.1. Market Size
    • 1.5.2. Market Share
    • 1.5.3. Key Data Points From Secondary Sources
    • 1.5.4. Key Data Points From Primary Sources
    • 1.5.5. Assumptions

2. Executive Summary

3. Market Overview

  • 3.1. Introduction
  • 3.2. Market Segmentation
  • 3.3. Market Dynamics
    • 3.3.1. Drivers & Restraint
      • 3.3.1.1. Rising Incidence Of Chronic And Infectious Diseases In Emerging Economies To Drive The Market
      • 3.3.1.2. Rapidly Aging Population
      • 3.3.1.3. Rise In Point-Of-Care (POC) Testing
      • 3.3.1.4. Personalized Medicine To Propel Growth
      • 3.3.1.5. Lack Of Budget To Restrict Growth
    • 3.3.2. Opportunities
      • 3.3.2.1. Extending Reach Of Molecular Diagnostics
      • 3.3.2.2. New Range Of Condition-Specific Markers And Tests With Advances In Genomics And Proteomics
    • 3.3.3. Challenge
      • 3.3.3.1. Stringent Regulatory Framework Acts As A Major Challenge
  • 3.4. Winning Imperatives
    • 3.4.1. Non-Proprietary System With Enhanced Functionalities
  • 3.5. Burning Issues
    • 3.5.1. Laboratory Automation For Increased Efficiency And Accurate Diagnosis
  • 3.6. Market Share Analysis
  • 3.7. Supply Chain Analysis
  • 3.8. Pestel Analysis
    • 3.8.1. Political
    • 3.8.2. Economic
    • 3.8.3. Socio-Cultural
    • 3.8.4. Technological
    • 3.8.5. Environmental
    • 3.8.6. Legal

4. Global In Vitro Diagnostic Market, By Technique

  • 4.1. Introduction
    • 4.1.1. Clinical Chemistry
    • 4.1.2. Immunochemistry/Immunoassay
    • 4.1.3. Hematology
    • 4.1.4. Coagulation
    • 4.1.5. Microbiology
    • 4.1.6. Molecular Diagnostics
    • 4.1.7. Other Clinical Instruments

5. Global In Vitro Diagnostic Market, By Product Type

  • 5.1. Introduction
  • 5.2. Instruments
  • 5.3. Reagents
  • 5.4. Data Management System Software/Hardware
  • 5.5. Services

6. Global In Vitro Diagnostic Market, By Application

  • 6.1. Introduction
  • 6.2. Diabetes
  • 6.3. Infectious Diseases
  • 6.4. Oncology/Cancer
  • 6.5. Cardiology
  • 6.6. Nephrology
  • 6.7. Autoimmune Diseases
  • 6.8. Drug Testing
  • 6.9. HIV/Aids
  • 6.10. Others

7. Global In Vitro Diagnostic Market, By End-User

  • 7.1. Introduction
  • 7.2. Laboratory
  • 7.3. Hospitals
  • 7.4. Academics
  • 7.5. Point-Of-Care Testing
  • 7.6. Patient Self-Testing
  • 7.7. Others

8. Geographic Analysis

  • 8.1. Introduction
  • 8.2. Americas
    • 8.2.1. U.S.
    • 8.2.2. Canada
    • 8.2.3. Mexico
    • 8.2.4. Chile
    • 8.2.5. Rest Of Americas (ROA)
  • 8.3. Europe
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. Italy
    • 8.3.4. Spain
    • 8.3.5. U.K.
    • 8.3.6. Rest Of Europe (ROE)
  • 8.4. Japan
  • 8.5. Bric
    • 8.5.1. Brazil
    • 8.5.2. Russia
    • 8.5.3. India
    • 8.5.4. China
  • 8.6. Rest Of The World (ROW)

9. Competitive Landscape

  • 9.1. Introduction
  • 9.2. New Product Launch
  • 9.3. Agreements, Partnerships, Collaborations & Joint Ventures
  • 9.4. Mergers And Acquisitions
  • 9.5. Other Developments

10. Company Profiles (Overview, Financials, Products & Services, Developments & Strategy)*

  • 10.1. Abbott Laboratories, Inc.
  • 10.2. Alere, Inc.
  • 10.3. Arkray, Inc.
  • 10.4. Bayer AG
  • 10.5. Becton, Dickinson And Company
  • 10.6. Biomerieux
  • 10.7. Bio-Rad Laboratories, Inc.
  • 10.8. Danaher Corporation
  • 10.9. Diagnostica Stago Sas
  • 10.10. Diasorin S.P.A.
  • 10.11. Hologic, Inc.
  • 10.12. Horiba, Ltd.
  • 10.13. Johnson & Johnson
  • 10.14. Novartis International Ag
  • 10.15. Qiagen N.V.
  • 10.16. Roche Diagnostics Limited
  • 10.17. Siemens Healthcare
  • 10.18. Sysmex Corporation
  • 10.19. Thermo Fisher Scientific, Inc.

*Details On Financials, Products & Services, Developments & Strategy Might Not Be Captured In Case Of Unlisted Companies.

List Of Tables

  • Table 1: Global In-Vitro Diagnostic Instrument & Reagents Market Revenue, By Technique, 2012 ($Million)
  • Table 2: Clinical Chemistry Market, By Geography, 2010 - 2017 ($Million)
  • Table 3: The Americas: Clinical Chemistry Market, By Country, 2010 - 2017 ($Million)
  • Table 4: Europe: Clinical Chemistry Market, By Country, 2010 - 2017 ($Million)
  • Table 5: BRIC: Clinical Chemistry Market, By Country, 2010 - 2017 ($Million)
  • Table 6: Global Clinical Chemistry Market, By Instruments & Reagents, 2010 - 2017 ($Million)
  • Table 7: Immunochemistry Market, By Geography, 2010 - 2017 ($Million)
  • Table 8: The Americas: Immunochemistry Market, By Country, 2010 - 2017 ($Million)
  • Table 9: Europe: Immunochemistry Market, By Country, 2010 - 2017 ($Million)
  • Table 10: BRIC: Immunochemistry Market, By Country, 2010 - 2017 ($Million)
  • Table 11: Global Immunochemistry Market, By Instruments & Reagents, 2010 - 2017 ($Million)
  • Table 12: Hematology Market, By Geography, 2010 - 2017 ($Million)
  • Table 13: The Americas: Hematology Market, By Country, 2010 - 2017 ($Million)
  • Table 14: Europe: Hematology Market, By Country, 2010 - 2017 ($Million)
  • Table 15: BRIC: Hematology Market, By Country, 2010 - 2017 ($Million)
  • Table 16: Global Hematology Market, By Instruments & Reagents, 2010 - 2017 ($Million)
  • Table 17: Coagulation Market, By Geography, 2010 - 2017 ($Million)
  • Table 18: The Americas: Coagulation Market, By Country, 2010 - 2017 ($Million)
  • Table 19: Europe: Coagulation Market, By Country, 2010 - 2017 ($Million)
  • Table 20: BRIC: Coagulation Market, By Country, 2010 - 2017 ($Million)
  • Table 21: Global Coagulation Market, By Instruments & Reagents, 2010 - 2017 ($Million)
  • Table 22: Microbiology Market, By Geography, 2010 - 2017 ($Million)
  • Table 23: The Americas: Microbiology Market, By Country, 2010 - 2017 ($Million)
  • Table 24: Europe: Microbiology Market, By Country, 2010 - 2017 ($Million)
  • Table 25: BRIC: Microbiology Market, By Country, 2010 - 2017 ($Million)
  • Table 26: Global Microbiology Market, By Instruments & Reagents, 2010 - 2017 ($Million)
  • Table 27: Molecular Diagnostics Market, By Geography, 2010 - 2017 ($Million)
  • Table 28: The Americas: Molecular Diagnostics Market, By Country, 2010 - 2017 ($Million)
  • Table 29: Europe: Molecular Diagnostics Market, By Country, 2010 - 2017 ($Million)
  • Table 30: BRIC: Molecular Diagnostics Market, By Country, 2010 - 2017 ($Million)
  • Table 31: Global Molecular Diagnostics Market, By Instruments & Reagents, 2010 - 2017 ($Million)
  • Table 32: Other In-Vitro Diagnostic Techniques Market, By Geography, 2010 - 2017 ($Million)
  • Table 33: The Americas: Other IVD Techniques Market, By Country, 2010 - 2017 ($Million)
  • Table 34: Europe: Other IVD Techniques Market, By Country, 2010 - 2017 ($Million)
  • Table 35: BRIC: Other IVD Techniques Market, By Country, 2010 - 2017 ($Million)
  • Table 36: Global In Vitro Diagnostic Market, By Product Type, 2010 - 2017 ($Million)
  • Table 37: In Vitro Diagnostic Instruments Market, By Geography, 2010 - 2017 ($Million)
  • Table 38: The Americas: IVD Instruments Market, By Country, 2010 - 2017 ($Million)
  • Table 39: Europe: IVD Instruments Market, By Country, 2010 - 2017 ($Million)
  • Table 40: BRIC: IVD Instruments Market, By Country, 2010 - 2017 ($Million)
  • Table 41: In Vitro Diagnostic Reagents Market, By Geography, 2010 - 2017 ($Million)
  • Table 42: The Americas: IVD Reagents Market, By Country, 2010 - 2017 ($Million)
  • Table 43: Europe: IVD Reagents Market, By Country, 2010 - 2017 ($Million)
  • Table 44: BRIC: IVD Reagents Market, By Country, 2010 - 2017 ($Million)
  • Table 45: In Vitro Diagnostic Data Management System Software/Hardware Market, By Geography, 2010 - 2017 ($Million)
  • Table 46: The Americas: IVD Data Management System Software/Hardware Market, By Country, 2010 - 2017 ($Million)
  • Table 47: Europe: IVD Data Management System Software/Hardware Market, By Country, 2010 - 2017 ($Million)
  • Table 48: BRIC: IVD Data Management System Software/Hardware Market, By Country, 2010 - 2017 ($Million)
  • Table 49: In Vitro Diagnostic Services Market, By Geography, 2010 - 2017 ($Million)
  • Table 50: The Americas: IVD Services Market, By Country, 2010 - 2017 ($Million)
  • Table 51: Europe: IVD Services Market, By Country, 2010 - 2017 ($Million)
  • Table 52: BRIC: IVD Services Market, By Country, 2010 - 2017 ($Million)
  • Table 53: Global In-Vitro Diagnostics Market, By Application, 2010 - 2017 ($Million)
  • Table 54: Diabetes In Vitro Diagnostic Market, By Geography, 2010 - 2017 ($Million)
  • Table 55: Americas: Diabetes IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 56: Europe: Diabetes IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 57: BRIC: Diabetes IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 58: Infectious Diseases In Vitro Diagnostics Market, By Geography, 2010 - 2017 ($Million)
  • Table 59: Americas: Infectious Diseases IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 60: Europe: Infectious Diseases IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 61: BRIC: Infectious Diseases IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 62: Oncology In Vitro Diagnostic Market, By Geography, 2010 - 2017 ($Million)
  • Table 63: Americas: Oncology IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 64: Europe: Oncology IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 65: BRIC: Oncology IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 66: Cardiology In Vitro Diagnostic Market, By Geography, 2010 - 2017 ($Million)
  • Table 67: Americas: Cardiology IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 68: Europe: Cardiology IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 69: BRIC: Cardiology IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 70: Nephrology In Vitro Diagnostic Market, By Geography, 2010 - 2017 ($Million)
  • Table 71: Americas: Nephrology IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 72: Europe: Nephrology IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 73: BRIC: Nephrology IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 74: Autoimmune Diseases In Vitro Diagnostic Market, By Geography, 2010 - 2017 ($Million)
  • Table 75: America: Autoimmune Diseases IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 76: Europe: Autoimmune Diseases IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 77: BRIC: Autoimmune Diseases IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 78: Drug Testing In Vitro Diagnostic Market, By Geography, 2010 - 2017 ($Million)
  • Table 79: Americas: Drug Testing IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 80: Europe: Drug Testing IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 81: BRIC: Drug Testing IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 82: HIV/Aids In Vitro Diagnostic Market, By Geography, 2010 - 2017 ($Million)
  • Table 83: Americas: Hiv/Aids IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 84: Europe: Hiv/Aids IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 85: BRIC: Hiv/Aids IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 86: Other Applications Market, By Geography, 2010 - 2017 ($Million)
  • Table 87: America: Other Applications Market, By Country, 2010 - 2017 ($Million)
  • Table 88: Europe: Other Applications Market, By Country, 2010 - 2017 ($Million)
  • Table 89: BRIC: Other Applications Market, By Country, 2010 - 2017 ($Million)
  • Table 90: Global In Vitro Diagnostics Market, By End-User, 2010 - 2017 ($Million)
  • Table 91: In Vitro Diagnostics Market, By Geography, 2010 - 2017 ($Million)
  • Table 92: Americas: IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 93: Americas: IVD Market, By Technique, 2010 - 2017 ($Million)
  • Table 94: Americas: IVD Market, By Application, 2010 - 2017 ($Million)
  • Table 95: Americas: IVD Market, By Product Type, 2010 - 2017 ($Million)
  • Table 96: U.S.: IVD Market, By Technique, 2010 - 2017 ($Million)
  • Table 97: U.S.: IVD Market, By Application, 2010 - 2017 ($Million)
  • Table 98: U.S.: IVD Market, By Product Type, 2010 - 2017 ($Million)
  • Table 99: Canada: IVD Market, By Technique, 2010 - 2017 ($Million)
  • Table 100: Canada: IVD Market, By Application, 2010 - 2017 ($Million)
  • Table 101: Canada: IVD Market, By Product Type, 2010 - 2017 ($Million)
  • Table 102: Mexico: IVD Market, By Technique, 2010 - 2017 ($Million)
  • Table 103: Mexico: IVD Market, By Application, 2010 - 2017 ($Million)
  • Table 104: Mexico: IVD Market, By Product Type, 2010 - 2017 ($Million)
  • Table 105: Chile: IVD Market, By Technique, 2010 - 2017 ($Million)
  • Table 106: Chile: IVD Market, By Application, 2010 - 2017 ($Million)
  • Table 107: Chile: IVD Market, By Product Type, 2010 - 2017 ($Million)
  • Table 108: ROA: IVD Market, By Technique, 2010 - 2017 ($Million)
  • Table 109: ROA: IVD Market, By Application, 2010 - 2017 ($Million)
  • Table 110: ROA: IVD Market, By Product Type, 2010 - 2017 ($Million)
  • Table 111: Europe: IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 112: Europe: IVD Market, By Technique, 2010 - 2017 ($Million)
  • Table 113: Europe: IVD Market, By Application, 2010 - 2017 ($Million)
  • Table 114: Europe: IVD Market, By Product Type, 2010 - 2017 ($Million)
  • Table 115: Germany: IVD Market, By Technique, 2010 - 2017 ($Million)
  • Table 116: Germany: IVD Market, By Application, 2010 - 2017 ($Million)
  • Table 117: Germany: IVD Market, By Product Type, 2010 - 2017 ($Million)
  • Table 118: France: IVD Market, By Technique, 2010 - 2017 ($Million)
  • Table 119: France: IVD Market, By Application, 2010 - 2017 ($Million)
  • Table 120: France: IVD Market, By Product Type, 2010 - 2017 ($Million)
  • Table 121: Italy: IVD Market, By Technique, 2010 - 2017 ($Million)
  • Table 122: Italy: IVD Market, By Application, 2010 - 2017 ($Million)
  • Table 123: Italy: IVD Market, By Product Type, 2010 - 2017 ($Million)
  • Table 124: Spain: IVD Market, By Technique, 2010 - 2017 ($Million)
  • Table 125: Spain: IVD Market, By Application, 2010 - 2017 ($Million)
  • Table 126: Spain: IVD Market, By Product Type, 2010 - 2017 ($Million)
  • Table 127: U.K.: IVD Market, By Technique, 2010 - 2017 ($Million)
  • Table 128: U.K.: IVD Market, By Application, 2010 - 2017 ($Million)
  • Table 129: U.K.: IVD Market, By Product Type, 2010 - 2017 ($Million)
  • Table 130: ROE: IVD Market, By Technique, 2010 - 2017 ($Million)
  • Table 131: ROE: IVD Market, By Application, 2010 - 2017 ($Million)
  • Table 132: ROE: IVD Market, By Product Type, 2010 - 2017 ($Million)
  • Table 133: Japan: IVD Market, By Technique, 2010 - 2017 ($Million)
  • Table 134: Japan: IVD Market, By Application, 2010 - 2017 ($Million)
  • Table 135: Japan: IVD Market, By Product Type, 2010 - 2017 ($Million)
  • Table 136: BRIC: IVD Market, By Country, 2010 - 2017 ($Million)
  • Table 137: BRIC: IVD Market, By Technique, 2010 - 2017 ($Million)
  • Table 138: BRIC: IVD Market, By Application, 2010 - 2017 ($Million)
  • Table 139: BRIC: IVD Market, By Product Type, 2010 - 2017 ($Million)
  • Table 140: Brazil: IVD Market, By Technique, 2010 - 2017 ($Million)
  • Table 141: Brazil: IVD Market, By Application, 2010 - 2017 ($Million)
  • Table 142: Brazil: IVD Market, By Product Type, 2010 - 2017 ($Million)
  • Table 143: Russia: Aging Population (Thousand)
  • Table 144: Russia: IVD Market, By Technique, 2010 - 2017 ($Million)
  • Table 145: Russia: IVD Market, By Application, 2010 - 2017 ($Million)
  • Table 146: Russia: IVD Market, By Product Type, 2010 - 2017 ($Million)
  • Table 147: India: IVD Market, By Technique, 2010 - 2017 ($Million)
  • Table 148: India: IVD Market, By Application, 2010 - 2017 ($Million)
  • Table 149: India: IVD Market, By Product Type, 2010 - 2017 ($Million)
  • Table 150: China: IVD Market, By Technique, 2010 - 2017 ($Million)
  • Table 151: China: IVD Market, By Application, 2010 - 2017 ($Million)
  • Table 152: China: IVD Market, By Product Type, 2010 - 2017 ($Million)
  • Table 153: ROW: IVD Market, By Technique, 2010 - 2017 ($Million)
  • Table 154: ROW: IVD Market, By Application, 2010 - 2017 ($Million)
  • Table 155: ROW: IVD Market, By Product Type, 2010 - 2017 ($Million)
  • Table 156: New Product Launch, 2011 - 2013
  • Table 157: Agreements, Partnerships, Collaborations & Joint Ventures, 2011 - 2013
  • Table 158: Mergers & Acquisitions, 2011 - 2013
  • Table 159: Othere Developments, 2011 - 2013
  • Table 160: Abbott Laboratories, Inc.: Major Developments, 2011 - 2013
  • Table 161: Alere, Inc.: Major Developments, 2011 - 20113
  • Table 162: Arkray, Inc.: Major Developments, 2011 - 2013
  • Table 163: Bayer Ag: Major Developments, 2011 - 2013
  • Table 164: Becton, Dickinson And Company: Major Developments, 2011 - 2013
  • Table 165: Biomerieux: Major Developments, 2011 - 2012
  • Table 166: Bio-Rad Laboratories, Inc.: Major Developments, 2011 - 2012
  • Table 167: Danaher Corporation: Major Developments, 2011 - 2013
  • Table 168: Diagnostica Stago Sas: Major Developments, 2011 - 2013
  • Table 169: Diasorin Inc.: Major Developments, 2011 - 2013
  • Table 170: Hologic, Inc.: Major Developments, 2011 - 2013
  • Table 171: Horiba, Ltd.: Major Developments, 2011 - 2012
  • Table 172: Johnson & Johnson: Major Developments, 2011 - 2012
  • Table 173: Novartis Ag: Major Developments, 2011 - 2012
  • Table 174: Qaigen N.V.: Major Developments, 2011 - 2013
  • Table 175: Roche Holdings: Major Developments, 2011 - 2013
  • Table 176: Siemens Healthcare: Major Developments, 2011 - 2013
  • Table 177: Sysmex Corporation: Major Developments, 2011 - 2013
  • Table 178: Thermo Fisher Scientific, Inc.: Major Developments, 2011 - 2013

List Of Figures

  • Figure 1: Global In-Vitro Diagnostic Instrument & Reagents Market,By Technique, 2012 ($Million)
  • Figure 2: Role Of In-Vitro Diagnostics In Healthcare
  • Figure 3: In Vitro Diagnostics Market Segmentation
  • Figure 4: In Vitro Diagnostics Market-Drivers & Restraints
  • Figure 5: Global In Vitro Diagnostics Market Share Analysis, By Key Player, 2012
  • Figure 6: In Vitrp Diagnostic Market:Supply Chain Analysis
  • Figure 7: In Vitro Diagnostic Market: Pestel Analysis
  • Figure 8: Global In Vitro Diagnostics Market Segmentation, By Technique
  • Figure 9: Global In Vitro Diagnostics Market, By Technique
  • Figure 10: Global In Vitro Diagnostics Market, By Geography, 2012
  • Figure 11: Key Growth Strategies, 2011 - 2013
  • Figure 12: Abbott Laboratories, Inc.: Total Revenue, By Segment, 2010 - 2012 ($Million)
  • Figure 13: Abbott Laboratories, Inc.: Market Strategy, 2011 - 2013
  • Figure 14: Alere, Inc.: Total Revenue, By Segment, 2009 - 2011 ($Million)
  • Figure 15: Alere, Inc.: Professional Diagnostics Revenue, By Segment, 2011 - 2012 ($Million)
  • Figure 16: Alere, Inc.: Market Strategy, 2011 - 2013
  • Figure 17: Arkray, Inc.: Market Strategy, 2011 - 2012
  • Figure 18: Bayer AG: Total Revenue, By Segment, 2010 - 2012 ($Million)
  • Figure 19: Becton, Dickinson And Company: Total Revenue, By Segment, 2010 - 2012 ($Million)
  • Figure 20: Bd Diagnostics: Total Revenue, By Segment, 2010 - 2012 ($Million)
  • Figure 21: Becton, Dickinson And Company: Market Strategy, 2011 - 2013
  • Figure 22: Biomerieux: Total Revenue, By Segment, 2010 - 2011 ($Million)
  • Figure 23: Biomerieux: Market Strategy, 2011 - 2012
  • Figure 24: Bio-Rad Laboratories, Inc.: Total Revenue, By Segment, 2010 - 2012 ($Million)
  • Figure 25: Bio-Rad Laboratories, Inc.: Market Srategy, 2011 - 2013
  • Figure 26: Danaher Corporation: Total Revenue, By Segment, 2010 - 2012 ($Million)
  • Figure 27: Danaher Corporation: Market Strategy, 2011 - 2013
  • Figure 28: Diagnostica Stago Sas: Market Strategy, 2011 - 2013
  • Figure 29: Diasorin S.P.A.: Total Revenue, By Technology, 2010 - 2012, ($Million)
  • Figure 30: Diasorin S.P.A,: Market Strategy, 2011 - 2013
  • Figure 31: Hologic, Inc.: Total Revenue, By Segment, 2010 - 2012 ($Million)
  • Figure 32: Hologic, Inc.: Market Srategy, 2011 - 2013
  • Figure 33: Horiba Ltd.: Total Revenue, By Segments, 2009 - 2011
  • Figure 34: Horiba, Ltd.: Market Strategy, 2011 - 2013
  • Figure 35: Johnson & Johnson: Total Revenue, By Segment, 2010 - 2012 ($Milllion)
  • Figure 36: Johnson & Johnson: Diagnostics Franchise Revenue, 2010 - 2012 ($Million)
  • Figure 37: Johnson & Johnson: Market Strategy, 2011 - 2013
  • Figure 38: Novartis AG: Total Revenue, By Segment, 2010 - 2012
  • Figure 39: Novartis AG: Market Stretegy, 2011 - 2013
  • Figure 40: Qiagen N.V.: Total Revenue, By Segment, 2010 - 2012 ($Million)
  • Figure 41: Qiagen N.V.: Market Srategy, 2011 - 2013
  • Figure 42: ROCHE Holdings: Diagnostics Revenue, By Segment, 2010 - 2012 ($Million)
  • Figure 43: ROCHE Holdings: Diagnostics Revenue, By Geography, 2010 - 2012 ($Million)
  • Figure 44: ROCHE Holdings: Market Strategy, 2011 - 2012
  • Figure 45: Siemens AG: Total Revenue, By Segment, 2010 - 2012 ($Million)
  • Figure 46: Siemens Healthcare: Market Strategy, 2011 - 2013
  • Figure 47: Sysmex Corporation: Diagnostics Segment Revenue, 2010 - 2012 ($Million)
  • Figure 48: Sysmex Corporation: Market Strategy, 2011 - 2013
  • Figure 49: Thermo Fisher Scientific, Inc.: Total Revenue, By Segment, 2010 - 2012 ($Million)
  • Figure 50: Thermo Fisher Scientific, Inc.: Market Srategy, 2011 - 2013
Back to Top